Share on LinkedInShare on LinkedIn

ARTICLE · 21 SEPTEMBER 2022

The FTC Picks A Fight Against The COPA Hospital Merger System

While regulators are signaling their goals to revise and strengthen merger enforcement, they are picking a fight against a particular obstacle to achieving their vision in health care.

United StatesAntitrust/Competition Law

While regulators are signaling their goals to revise and strengthen merger enforcement, they are picking a fight against a particular obstacle to achieving their vision in health care. Specifically, the Federal Trade Commission (FTC) is currently pushing states to restrict their use of Certificates of Public Advantage (COPAs).

COPAs are state statutes that provide state regulatory oversight over health systems mergers and collaborations that immunize them from antitrust scrutiny under the state action doctrine exemption. The general purpose of a COPA is to allow mergers that otherwise may not pass antitrust scrutiny because the merger benefits the public. As of today, 18 states (including Texas, Florida and New York) maintain COPA regimes. Five states that previously maintained COPA regimes have repealed them (NC, CO, MT, ND and MN), with some COPA systems having been in operation for many years.1 The COPA concept was initially developed to facilitate

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from